Clinical Trials Directory

Trials / Unknown

UnknownNCT00972400

Fatigue in Breast Cancer Survivors

Biological Mechanisms of Fatigue in Breast Cancer Survivors

Status
Unknown
Phase
Study type
Observational
Enrollment
96 (estimated)
Sponsor
St George's, University of London · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

RATIONALE: Gathering information over time from blood samples and measurements of activity, sleep, mood, and cognition may help doctors learn more about fatigue in breast cancer survivors and plan the best treatment. PURPOSE: This clinical trial is studying fatigue in breast cancer survivors.

Detailed description

OBJECTIVES: * To investigate the relationship between fatigue severity; protein biomarkers; and measures of activity, sleep, mood, and cognition in breast cancer survivors. * To identify and quantify serum biomarkers and underlying biological pathways unique to cancer-related fatigue syndrome in these survivors. * To map changes over time in order to explore the inter-relationships between these variables. OUTLINE: Participants undergo fatigue assessment by the Diagnostic Interview for Cancer Related Fatigue and the FACT-Fatigue questionnaire; psychological symptoms assessment by the Structured Clinical Interview for DSM-IV, Hospital Anxiety and Depression Scale, and the Insomnia Severity Index questionnaires; and quality of life assessment by the EORTC-QLQc30 and EORTC-QLQ-BR23 questionnaires twice approximately 3 months apart. Participants also undergo activity level, circadian rhythm, and sleep measurements by the Micro-mini® Motionlogger actigraphy and measurement of cognitive disturbances by the Cantabeclipse™ technology. Participants undergo blood sample collection for protein analysis by 2D gel electrophoresis and mass spectrometry.

Conditions

Interventions

TypeNameDescription
GENETICprotein analysis
OTHERlaboratory biomarker analysis
OTHERmass spectrometry
OTHERquestionnaire administration
PROCEDUREassessment of therapy complications
PROCEDUREcognitive assessment
PROCEDUREquality-of-life assessment

Timeline

Start date
2009-01-01
Primary completion
2011-01-01
First posted
2009-09-04
Last updated
2013-08-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00972400. Inclusion in this directory is not an endorsement.